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Objective: To evaluate the impact of rapid syphilis tests (RSTs) on syphilis testing and treatment in pregnant
women in Kalomo District, Zambia.Methods: In March 2012, health workers at all 35 health facilities in Kalomo
Distract were trained in RST use and penicillin treatment. In March 2013, data were retrospectively abstracted
from 18 randomly selected health facilities and stratiﬁed into three time intervals: baseline (6 months prior to
RST introduction), midline (0–6 months after RST introduction), and endline (7–12 months after RST introduc-
tion). Results: Data collected on 4154 pregnant women showed a syphilis-reactive seroprevalence of 2.7%. The
proportion of women screened improved from baseline (140/1365, 10.6%) to midline (976/1446, 67.5%), ﬁnally
decreasing at endline (752/1337, 56.3%) (P b 0.001). There was no signiﬁcant difference in the proportion of
syphilis-seroreactive pregnant women who received 1 dose of penicillin before (1/2, 50%) or after (5/48,
10.4%; P = 0.199) RST introduction with low treatment rates throughout. Conclusion: With RST scale-up in
Zambia and other resource-limited settings, same-day test and treatment with penicillin should be prioritized
to achieve the goal of eliminating congenital syphilis.
© 2015 World Health Organization; licensee Elsevier. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Background
Globally, it is estimated that approximately 1.4 million annual cases
of syphilis occur during pregnancy [1]. A recent meta-analysis demon-
strated that, among asymptomatic, untreated pregnant women with
syphilis, fetal loss and stillbirth, neonatal deaths, and prematurity/low
birth weight were 21%, 9.3%, and 5.8%, respectively, more frequent
when compared with women without syphilis [2]. Treatment of
syphilis-seroreactive pregnant women with 1 dose of intramuscular
penicillin at least 30 days prior to delivery reduces the risk of adverse
pregnancy outcomes to that of a non-infected mother, although full
treatment of latent maternal syphilis requires three doses of intramus-
cular penicillin [3–5]. However, modeling data suggest that less thanand Development, Crosstown
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witz).
Elsevier. This is an open access art10% of women with syphilis during pregnancy are screened and
appropriately treated [1], despite the 2007 World Health Organization’s
Global Elimination of Congenital Syphilis initiative goals of testing
more than 90% of pregnant women and of treating more than 90% of
those who are seroreactive by 2015 [6].
Recently-developed rapid syphilis tests (RST; BIOLINE, Korea) have a
high sensitivity (85.7% to 100%) and speciﬁcity (96% to 100%), and do
not require the traditional laboratory infrastructure used for rapid
plasma reagin (RPR) tests [7–9]. Previous studies have suggested
increased syphilis screening post-RST implementation, but longer-
term evaluation of screening rates after initial training is needed [10].
In March 2012, the Elizabeth Glaser Pediatric Aids Foundation complet-
ed RST training and implementation in accordance with the Zambian
Ministry of Health (MOH) guidelines [11,12] for antenatal care (ANC)
staff in KalomoDistrict, Zambia. The present study evaluates the perfor-
mance of RSTs and treatment of seropositive women in ANC facilities
12 months after RST implementation and describes the impact
of RST use on ANC and prevention of mother-to-child transmission
(PMTCT) services.icle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.1. Study site selection and standard of care
Kalomo is a rural districtwith a population of 254 211 (2010 census)
in an area of approximately 15 000 km2with onemain tarmac road [13].
Prior to March 2012, RPR tests were used during ANC to screen for
syphilis. InMarch 2012, 35MOH staff from all 35 facilities in Kalomo re-
ceived off-site training for RST and syphilis treatment, with intermittent
on-site supervision at some facilities afterwards. Of these 35 facilities,
18 were selected by random-number generator, and included 1 urban
district hospital, 2 urban health centers, and 15 rural health centers.
All facilities provide antenatal PMTCT of HIV services, which at the
time of the study included HIV testing, partner testing, and referral to
antiretroviral therapy services, as well as under-ﬁve pediatric services,
free of charge. The selected facilities had a mean of 39.3 ﬁrst ANC visits
per month (range, 8.5−70.3). The study population discussed herein
included a random sample of pregnant women attending their ﬁrst
ANC visits at any of these 18 facilities.
2.2. Study design
The study followed a quasi-experimental evaluation design with
baseline, midline, and endline comparisons. Data on pregnant women
were retrospectively abstracted using facility registers from September
2011 to March 2013 and stratiﬁed into three intervals, namely baseline
(6 months prior to introduction of RSTs), midline (0 to 6 months after
introduction of RSTs), and endline (7 to 12 months after introduction
of RSTs). The primary outcome was the proportion of pregnant
women screened for syphilis at the ﬁrst ANC visit. Secondary outcomes
were: (1) the proportion of syphilis-seroreactive women treated with
penicillin; (2) the proportion of women seroreactive for HIV and
syphilis; and (3) the proportion of syphilis-seroreactive women with
poor pregnancy outcomes (i.e. low birth weight (b2500 g), premature
delivery (b37 weeks), stillbirth). For the purposes of the present
study, stillbirth was deﬁned as any birth outcome recorded by health
facility staff as a stillbirth (fresh ormacerated) in the Labor and Delivery
register. The Zambian MOH training deﬁnes stillbirth as any fetus born
at more than 28 weeks of gestation without a heartbeat [11].
2.3. Data collection
Ten data collectors from Kalomo District were trained and tested in
research ethics, standardized data extraction, and management tech-
niques prior to data collection. Data capture was done using TeleForms
(Hewlett-Packard, Palo Alto, CA, USA) [14]. Pregnant women attending
their ﬁrst ANC visit during the observation period were randomly
selected from the MOH-approved Safe Motherhood (SMH) register
using a sequential skip pattern dependent on ANC volume at the facility.
Facilities with less than 12 ﬁrst ANC visits permonth randomly sampled
every otherwoman in the SMH register; all other facilities (with a range
of 16−70 ﬁrst ANC visits per month) randomly sampled every fourth
woman in the SMH register across all three time periods. Women
were identiﬁed by a unique SMH number and tracked across other
MOH-approved, standardized registers, including the Integrated
PMTCT register, the Labor and Delivery register, and facility RST logs.
Abstracted data for analysis included information on (1) syphilis testing,
(2) syphilis treatment, (3) HIV testing, and (4) delivery for mother/
infant pairs. All women randomly selected from the SMH register were
included in the analysis, even if they could not be traced to delivery.
Stockout data for testing materials and penicillin were abstracted from
facility pharmaceutical and supply logs. Baseline testing values were
calculated using data from the 6 (33.3%) facilities that had RPR testing
materials in stock. Twelve facilities (66.7%)were not performing antena-
tal syphilis screening prior to the introduction of RST and thus baseline
data were not available for analysis. There was no documentation ofany conﬁrmatory RPR tests performed for any positive RSTs at the facility
level. Veriﬁcation and completeness of forms was done in the ﬁeld by
data supervisors. Formswere then sent to the central data processing of-
ﬁce and scanned using TeleForm software, allowing for double-data
entry compiled into a password-protected Microsoft Access (Microsoft,
Redmond, WA, USA) database.
2.4. Data analysis
Differences in patient outcomes between index (baseline) and
comparison groups (midline and endline) were calculated using
Pearson’s χ2 test or Fisher exact test. A P value of less than 0.05 was
considered statistically signiﬁcant. SAS version 9.3 (SAS Institute Inc.,
Cary, NC, USA) was used for all analyses.
2.5. Ethics
Theprotocol for the studywas reviewed and approved by the Boston
University Institutional Review Board, the ERES Converge Zambian
Institutional Review Board, and the Centers for Disease Control and
Prevention’s Associate Director for Science.
3. Results
3.1. Demographic and ANC characteristics
ANC data from 4154 pregnant women presenting to any of the 18
selected ANC facilities during the observation period were collected
and analyzed (Table 1). ANC demographic data were missing for 19
women across all three time periods. Median gestational age at ﬁrst
ANC visit was 22 weeks (range, 7−39) across the three time intervals.
The median number of visits for the study population was 1 ANC visit
across all time periods (median, 1; range, 1−6).
3.2. Performance of syphilis screening
At baseline, 10.3% (140/1365) of women were screened for syphilis
at their ﬁrst ANC visit by RPR testing (Table 2). Within the ﬁrst
6 months following the introduction of RSTs, testing increased to
67.5% (976/1446) of women across all 18 facilities, ﬁnally dropping to
56.3% (752/1337) at endline (P b0.001 for both midline and endline
compared with baseline).
3.3. Syphilis and HIV seropositivity
Syphilis seroreactivity prevalence in the study population was 2.7%
(50/1868), with no signiﬁcant differences across the three time periods.
HIV seropositivity was 4.5%, with no signiﬁcant differences across the
three time periods. HIV testing data was available for all 4154 women
included in the study.
3.4. Treatment and birth outcomes of syphilis-seroreactive women
In the baseline group, 1 of 2 syphilis-seroreactive women was
treated with 1 dose of penicillin. During the ﬁrst 6 months following
RST introduction, only 13% (3/23) of seroreactive women received 1
dose of penicillin, and 7−12 months after RST introduction, 8% (2/25)
of seroreactive women received 1 dose of penicillin (Table 2). Timing
of treatment was not reliably recorded. Birth outcome data from Labor
and Delivery registers were available for 19.3% (802/4154) of women
in the study population, 1.5% (12) of whom had tested syphilis
seroreactive at their ﬁrst ANC visit; these 12 women had documented
live births, but birth weight and gestational age data were not available
in the Labor andDelivery register. Treatmentwith at least 1 dose of pen-
icillin was documented for three women, but there was no
Table 1
Characteristics of pregnant women presenting to ﬁrst antenatal care (ANC) visit.
Baseline Midline Endline Total P value
Total no. 1361 1441 1333 4135
Median gestational age, weeks (range) 22 (8–38) 21 (7–38) 21 (7–39) 22 (7–39)
Median number of ANC visits (range) 1 (1–6) 1 (1–6) 1 (1–6) 1 (1–6)
Number of HIV-positive women (%) 57 (4.2) 70 (4.9) 60 (4.5) 187 (4.5) 0.72
Table 2
Proportion of pregnant women tested and treated.a
Baseline
(n = 1365)
Midline
(n = 1446)
Endline
(n = 1337)
Total
(n = 4148)
P value
Received RPR as ﬁrst test 140 (10.3) 0 0 140 (33.8)
Received RST as ﬁrst test 0 976 (67.5) 752 (56.3) 1728 (41.7) b0.001
Positive ﬁrst test 2 (1.4) 23 (2.4) 25 (3.3) 50 (2.7) 0.015
Received 1 penicillin dose 1 (50) 3 (13) 2 (8) 6 (12) 0.1992
Abbreviation: RPR, rapid plasma reagin; RST, rapid syphilis tests.
a Values are given as number (percentage) unless otherwise indicated.
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women or for infants for whom we had delivery data.3.5. HIV and syphilis
At baseline, 28% (16/57) of HIV-positive women were tested
for syphilis by RPR; at midline and endline, 86.8% (59/68) and 66.1%
(39/59) of HIV-positive women were tested for syphilis, respectively.
HIV-positive women were more likely than the general population to
receive syphilis testing, regardless of the time period (P b 0.001;
Table 3). Of the 114 women testing HIV-positive at their ﬁrst ANC
visit, 5.3% (n = 6) were also seropositive for syphilis, but only 1
(16.7%) woman positive for both syphilis and HIV was treated with
penicillin. HIV testing rates were not affected by RST testing; across all
periods, 81.2% (3374/4154) of women presenting to their ﬁrst ANC
visit received an HIV test, with no signiﬁcant differences in HIV testing
between time periods (Table 3).3.6. Stockouts
Analysis of stockouts affecting testing uptake was performed for 15
of the 18 facilities evaluated in the study since three facilities did not
have pharmaceutical and laboratory supply logs. During the baseline
period, of the facilities that had RPR tests available, 33.3% (2/6) had doc-
umented periods of RPR stockouts, ranging from 8−20 weeks. During
the midline period, 33% (5/15) of the facilities had documented
stockouts of RSTs, ranging from 4−12 weeks, with a median stockout
period of 6 weeks. During the endline period, 60% (9/15) of the facilities
had stockouts, ranging from 1−16 weeks, with a median stockout peri-
od of 5.5 weeks. However, throughout the entire observation period
therewere no documented stockouts of penicillin at any health facilities
according to the facility pharmaceutical logs.Table 3
HIV and syphilis seroprevalence at ﬁrst antenatal care visit.a
Baseline
(n = 1366)
Women tested for HIV 1,121 (82.1)
Number of HIV-positive women 57 (4.2)
Number of HIV-positive women tested for syphilis 16 (28)
Number of women positive for HIV and syphilis 0 (0)
a Values are given as number (percentage) unless otherwise indicated.4. Discussion
The present evaluation demonstrated that introduction of RSTs
signiﬁcantly improved syphilis testing uptake in the six months
immediately after introduction; however, testing decreased to some
degree in the 6−12 months following. These ﬁndings are similar to a
prior study performed in Zambia [10], which demonstrated an increase
in screening uptake from 17.1% to 95.6% (urban areas) and 36.9% to 96%
(rural areas) with RST use, but only up to ﬁve months after RST
introduction. However, there was no evaluation up to 12 months or
assessment of potential drop-off after initial staff training. Recently,
a Kenyan evaluation demonstrated increased testing uptake at
12 months following initial RST training, but did not provide data
regarding initial use of RST immediately after training [15].
Stockouts of testing supplies occurred frequently, likely affecting
screening coverage and performance after RST introduction. Analysis
of stockout patterns demonstrated an increased number of facilities
with RST test kit stockouts during the endline period, although the
median lengthof stockout timewas similar to that in themidline period.
Nevertheless, the increase in number of ANC facilities experiencing
stockouts during the endline period does not fully explain the lower
rates of RST observed in the endline period compared with the midline
period. Shifts in trained staff members and lack of sustained on-site
supervision may help explain the lower rates of RST use in the endline
comparedwith themidline. Regardless, however, supply chainmanage-
ment remains a crucial aspect of implementing RSTs.
The syphilis seropositivity rate of 2.7% was comparable to values
reported in other Sub-Saharan African countries [16]. The availability
of treatment was extremely limited, with only 12% of seropositive
women across all three time periods having received at least 1 dose of
penicillin. Taking into account the missed testing opportunities, a
smaller prevalence of syphilis was found in this district using RPR
tests and RST (2.7%) compared with estimates from prior national sur-
vey data, which used RPR testing alone (4% to 7%) [17]. Prior studiesMidline
(n = 1449)
Endline
(n = 1339)
Total
(n = 4154)
P value
1,225 (84.5) 1,028 (76.8) 3,374 (81.2) 0.33
68 (4.7) 59 (4.4) 187 (4.5) 0.72
59 (86.8) 39 (66.1) 114 (60.9) b0.001
1 (1.6) 5 (12.8) 6 (5.3) b0.001
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syphilis seroprevalence rates of 12% being reported in pregnant
women in Mongu, a rural district, and rates of 3.5% being reported in
Lusaka [10]; a different study found a 6% seroprevalence rate among
ANC attendees in Lusaka [18]. Variations in test positivity may be ex-
plained by differences in test technology, where the RPR test identiﬁes
a nonspeciﬁc antibody that can be present in the absence of syphilis,
while RST assesses syphilis-speciﬁc antibodies [19,20].
Documentation of treatment was available for only a few women
testing positive for syphilis. While signiﬁcant differences between
treatment rates were not observed, the sample size was too small to
conclude any substantive change in treatment rates following introduc-
tion of RST. Further, it can be concluded that poor treatment rates were
never a result of penicillin stockouts since these were not observed.
Thus, the poor treatment rates observed are either due to the actual
lack of provision of treatment or the dearth of treatment documenta-
tion. With the scale-up of RST implementation in Zambia and
elsewhere, a focus on the treatment of seroreactive women is essential
to ensure the intended impact of this investment. A recent article de-
scribed similar results inKenya,whereno treatment datawere recorded
for any woman tested following the introduction of RSTs [15].
Women who were HIV positive were more likely to be tested for
syphilis; indeed, 5.3% of HIV-positive women tested seroreactive for
syphilis. However, co-infected womenwere not more likely to be treat-
ed with penicillin. Though there was a small sample size and
low prevalence of syphilis documented in the study population, the
proportion of women seen to be co-infected is larger than other esti-
mates from Sub-Saharan Africa, with syphilis and HIV co-infection
rates of 0.9% and 1.4% being recently observed in Tanzania [21,22].
Introduction of RST testing did not affect facility-level rates of HIV test-
ing uptake for pregnant women, which remained above 77% at all time
periods compared. Since 2007, all MOH facilities in Kalomo have had
on-site monthly mentorship of PMTCT services, including HIV testing.
This, coupled with the considerable length of time during which HIV
testing has been a routine part of ANC care, may help explain the higher,
consistent rates of rapidHIV testing comparedwith those of the similarly-
performed RST.
In Kalomo, infant delivery rates at health facilities are generally
low; 2007 data showed a 47% facility delivery rate [17] and unpublished
data from a recent cluster-randomized control trial with active
follow-up demonstrated a 51.3% facility delivery rate [Zambia
Chlorhexidine Application Trial, in preparation; 2014]. The limitations
of retrospective data collection likely account for themuch lower facility
delivery rate of 19.3% seen in the present study. Poor documentation at
the facilities limited our ability to trace women from antenatal records
to delivery records, and to trace women delivering at a different facility
than where they received ANC. Given the lack of documentation
on infant data, it is impossible to draw any conclusions regarding
infant outcomes.
Additional limitations to this retrospective study include its lack of
generalizability, since it was performed in a single district, and its
reliance on retrospective data from facility-based registers, making it
impossible to distinguish between poor documentation and poor clini-
cal practice. Reliable records of current facility staff previously trained
in RSTswere difﬁcult to obtain, thusmaking it challenging to determine
whether the observed decrease in testing was due to untrained staff.
Qualitative studies are needed to help identify factors affecting testing
uptake at the facility level.
This evaluation demonstrates the adoption of new diagnostics in
resource-limited settings after an initial training period; however,
contrary to previously published studies [10], it demonstrates a drop-
off in testing with time. The highest increase in testing uptake was
observed during the ﬁrst six months following RST introduction
(including the introductory phase of RSTs). The initial increase in test-
ing uptake then fell over the subsequent six months, albeit maintaining
a signiﬁcant increase from baseline. However, assessment of RSTsustainability may be best conducted at a time point longer than
12months following initial adoption of RSTs. Stockouts of RSTs impact-
ed testing rates, but do not fully account for the drop-off in testing rates
from midline to endline time periods. Trained staff shifts and lack of
sustained RST supervision may also have contributed to this decline in
testing rates.
Most importantly, the lack of impact that increased screening had on
the treatment of syphilis-seroreactive women needs to be urgently ad-
dressed. All staff trained in RST should be trained in penicillin adminis-
tration to optimize the beneﬁts of RST, aiming to provide simultaneous
same-day testing and treatment with a single dose of penicillin.
Additionally, the dismal lack of information about infants born to
syphilis-seroreactive women represents a dismal gap in care for these
mothers and infants.
5. Conclusions
While the promise of point-of-care testing for treatable conditions
such as syphilis is great, the challenge of sustaining new point-of-care
technologies is considerable. Variables affecting testing performance in-
clude stockouts, trained staff turn-over, lack of sustained supervision
after training, and overburdening of staff. Emphasis on sustained staff
training, commodity management, and adequate data collection is
required during RST scale-up in resource-limited settings. Further,
through the RST scale-up in Zambia and elsewhere, appropriate
treatment for women identiﬁed to be syphilis-seroreactive is essential
for the elimination of mother-to-child transmission of syphilis.
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